A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer
- 1 September 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1992
- Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder CancerJournal of Urology, 1992
- Transurethral Resection and Intravesical Therapy of Superficial Bladder TumorsUrologic Clinics of North America, 1991
- Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder CancerEuropean Urology, 1991
- MULCOX: a computer program for the Cox regression analysis of multiple failure time variablesComputer Methods and Programs in Biomedicine, 1990
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Intravesical Thiotepa versus Mitomycin C in Patients with TA, T1 and TIS Transitional Cell Carcinoma of the Bladder: A Phase III Prospective Randomized StudyJournal of Urology, 1988
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- Restricted Randomization Designs in Clinical TrialsBiometrics, 1979